Clinical Trial Update: Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of P-3074 topical solution for androgenetic alopecia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• P-3074

Snippet

Sponsor: Polichem S.A. | Conditions: Alopecia, Androgenetic | Phase 3 | Status: COMPLETED | Results posted: 2019-04-19